18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Cu2+accentuates distinct misfolding of Aβ(1–40)and Aβ(1–42)peptides, and potentiates membrane disruption

      , ,
      Biochemical Journal
      Portland Press Ltd.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Central to Alzheimer's disease is the misfolding of amyloid-beta (Aβ) peptide, which generates an assorted population of amorphous aggregates, oligomers and fibres. Metal ion homoeostasis is disrupted in the brains of sufferers of Alzheimer's disease and causes heightened Alzheimer's disease phenotype in animal models. In the present study, we demonstrate that substochiometric Cu²⁺ affects the misfolding pathway of Aβ₁₋₄₀, and the more toxic Aβ₁₋₄₂, in markedly different ways. Cu²⁺ accelerates Aβ₁₋₄₀ fibre formation. In contrast, for Aβ₁₋₄₂, substoichiometric levels of Cu²⁺ almost exclusively promote the formation of oligomeric and protofibrillar assemblies. Indeed, mature Aβ₁₋₄₂ fibres are disassembled into oligomers when Cu²⁺ is added. These Cu²⁺ stabilized oligomers of Aβ₁₋₄₂ interact with the lipid bilayer, disrupting the membrane and increasing permeability. Our investigation of Aβ₁₋₄₀/Aβ₁₋₄₂ mixtures with Cu²⁺ revealed that Aβ₁₋₄₀ neither contributed to nor perturbed formation of Aβ₁₋₄₂ oligomers, although Cu²⁺-Aβ₁₋₄₂ does frustrate Cu²⁺-Aβ₁₋₄₀ fibre growth. Small amounts of Cu²⁺ accentuate differences in the propensity of Aβ₁₋₄₀ and Aβ₁₋₄₂ to form synaptotoxic oligomers, providing an explanation for the connection between disrupted Cu²⁺ homoeostasis and elevated Aβ₁₋₄₂ neurotoxicity in Alzheimer's disease.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          A specific amyloid-beta protein assembly in the brain impairs memory.

          Memory function often declines with age, and is believed to deteriorate initially because of changes in synaptic function rather than loss of neurons. Some individuals then go on to develop Alzheimer's disease with neurodegeneration. Here we use Tg2576 mice, which express a human amyloid-beta precursor protein (APP) variant linked to Alzheimer's disease, to investigate the cause of memory decline in the absence of neurodegeneration or amyloid-beta protein amyloidosis. Young Tg2576 mice ( 14 months old) form abundant neuritic plaques containing amyloid-beta (refs 3-6). We found that memory deficits in middle-aged Tg2576 mice are caused by the extracellular accumulation of a 56-kDa soluble amyloid-beta assembly, which we term Abeta*56 (Abeta star 56). Abeta*56 purified from the brains of impaired Tg2576 mice disrupts memory when administered to young rats. We propose that Abeta*56 impairs memory independently of plaques or neuronal loss, and may contribute to cognitive deficits associated with Alzheimer's disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.

            Mutations in the genes encoding amyloid-beta precursor protein (APP), presenilin 1 (PS1) and presenilin 2 (PS2) are known to cause early-onset, autosomal dominant Alzheimer's disease. Studies of plasma and fibroblasts from subjects with these mutations have established that they all alter amyloid beta-protein (beta APP) processing, which normally leads to the secretion of amyloid-beta protein (relative molecular mass 4,000; M(r) 4K; approximately 90% A beta1-40, approximately 10% A beta1-42(43)), so that the extracellular concentration of A beta42(43) is increased. This increase in A beta42(43) is believed to be the critical change that initiates Alzheimer's disease pathogenesis because A beta42(43) is deposited early and selectively in the senile plaques that are observed in the brains of patients with all forms of the disease. To establish that the presenilin mutations increase the amount of A beta42(43) in the brain and to test whether presenilin mutations act as true (gain of function) dominants, we have now constructed mice expressing wild-type and mutant presenilin genes. Analysis of these mice showed that overexpression of mutant, but not wild-type, PS1 selectively increases brain A beta42(43). These results indicate that the presenilin mutations probably cause Alzheimer's disease through a gain of deleterious function that increases the amount of A beta42(43) in the brain.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Metals in Alzheimer's and Parkinson's diseases.

              There has been steadily growing interest in the participation of metal ions (especially, zinc, copper, and iron) in neurobiological processes, such as the regulation of synaptic transmission. Recent descriptions of the release of zinc and copper in the cortical glutamatergic synapse, and influencing the response of the NMDA receptor underscore the relevance of understanding the inorganic milieu of the synapse to neuroscience. Additionally, major neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease, are characterized by elevated tissue iron, and miscompartmentalization of copper and zinc (e.g. accumulation in amyloid). Increasingly sophisticated medicinal chemistry approaches, which correct these metal abnormalities without causing systemic disturbance of these essential minerals, are being tested. These small molecules show promise of being disease-modifying.
                Bookmark

                Author and article information

                Journal
                Biochemical Journal
                Biochem. J.
                Portland Press Ltd.
                0264-6021
                1470-8728
                March 01 2015
                March 01 2015
                March 01 2015
                March 01 2015
                : 466
                : 2
                : 233-242
                Article
                10.1042/BJ20141168
                25471541
                18824dc9-ec61-453a-a492-40e9291b36a9
                © 2015
                History

                Comments

                Comment on this article